ConductScience.org, home

Paper2199065

Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.

Schumacher TN and 5 others. Cell, 1990. Cited by 448 papers, by iCite.

Cite this record

ConductScience Library. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Papers, record 2199065. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2199065

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.
PubMed
Journal
Cell
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
448
iCite
Relative citation ratio, by iCite
7.85
iCite
Revised in PubMed
2019-07-05
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schumacher TNT N
2Heemels MTM T
3Neefjes JJJ J
4Kast WMW M
5Melief CJC J
6Ploegh HLH L

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Histocompatibility Antigens Class IMajor topic
Animals
Cell Line
Cell Membrane
Electrophoresis, Polyacrylamide Gel
H-2 Antigens
Immunoenzyme Techniques
Mice
Peptides
Protein Binding

Source PubMed

Download CSV of topics

Cited by124

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 448 citations.

PMIDTitleJournalYearIn PapersSource
42646732Immunoinformatics-Driven Rational Design of Altered Peptide Ligands and In Vitro Validation of a Multi-Epitope CTL Formulation Targeting HPV16 E6/E7.Vaccines (Basel)2026https://conductscience.org/library/papers/42646732PubMed
42191216Systematic Evaluation of Peptidomimetic Modifications in a Major Histocompatibility Complex Class I Model Epitope: A Framework for Immunogenic Antigen Design.ACS Chem Biol2026https://conductscience.org/library/papers/42191216PubMed
41726884A Framework for Comparing Mouse Neoantigen Immunogenicity.bioRxiv2026https://conductscience.org/library/papers/41726884PubMed
40091029IL-4 mediated TAP2 downregulation is a dominant and reversible mechanism of immune evasion and immunotherapy resistance in non-small cell lung cancer.Mol Cancer2025https://conductscience.org/library/papers/40091029PubMed
39150956A Chemical Approach to Assess the Impact of Post-translational Modification on MHC Peptide Binding and Effector Cell Engagement.ACS Chem Biol2024https://conductscience.org/library/papers/39150956PubMed
38930438Immunogenicity Analysis and Identification of Potential T-Cell Epitopes in C129R Protein of African Swine Fever Virus.Microorganisms2024https://conductscience.org/library/papers/38930438PubMed
38665920Targeted acidosis mediated delivery of antigenic MHC-binding peptides.Front Immunol2024https://conductscience.org/library/papers/38665920PubMed
38426497Cancer neoepitopes viewed through negative selection and peripheral tolerance: a new path to cancer vaccines.J Clin Invest2024https://conductscience.org/library/papers/38426497PubMed
38239352MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.Front Immunol2023https://conductscience.org/library/papers/38239352PubMed
37310998Universal open MHC-I molecules for rapid peptide loading and enhanced complex stability across HLA allotypes.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37310998PubMed
36722462Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes.Elife2023https://conductscience.org/library/papers/36722462PubMed
36134954Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis.Antibodies (Basel)2022https://conductscience.org/library/papers/36134954PubMed
35651601Molecular Determinants Regulating the Plasticity of the MHC Class II Immunopeptidome.Front Immunol2022https://conductscience.org/library/papers/35651601PubMed
35647522Homotypic and heterotypic in cis associations of MHC class I molecules at the cell surface.Curr Res Immunol2022https://conductscience.org/library/papers/35647522PubMed
35087915A Combinatorial in-silico, in-vitro and in-vivo Approach to Quantitatively Study Peptide Induced MHC Stability.Bio Protoc2021https://conductscience.org/library/papers/35087915PubMed
34534464Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors.Cell2021https://conductscience.org/library/papers/34534464PubMed
34205517Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg.Vaccines (Basel)2021https://conductscience.org/library/papers/34205517PubMed
33963786Immune Checkpoint-Bioengineered Beta Cell Vaccine Reverses Early-Onset Type 1 Diabetes.Adv Mater2021https://conductscience.org/library/papers/33963786PubMed
33476307Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.J Clin Invest2021https://conductscience.org/library/papers/33476307PubMed
31201791MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.Anal Biochem2019https://conductscience.org/library/papers/31201791PubMed

See all 124 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2199065

GET https://conductscience.org/api/papers/v1/2199065/cited_by?page=2